HomeHealthcareModerna Says Updated COVID...

Moderna Says Updated COVID Shot Strengthens Omicron Protection –

Moderna’s experimental COVID-19 vaccine, which combines its initial shock with protection against the omicron variant, seems to be working, the company said Wednesday.

The creators of the COVID-19 vaccine are studying updated amplifiers they will offer in the fall to better protect people from future corovirus waves.

The results of a preliminary Moderna study showed that people who received a combined stroke experienced an eight-fold increase in anti-virus antibodies that could target the omcron mutant, the company said.

COVID-19 vaccines are now all based on the original version of the coronavirus. They still provide strong protection against serious illness, hospitalization, and death even after the super-contagious variant of omicron appears, especially if people have had a booster dose.

But the virus continues to mutate so quickly that it can bypass some vaccine protection and cause milder infections.

So U.S. regulators and the World Health Organization are considering whether to mandate a change in the vaccine prescription for a new phase of vaccine boosting in the fall, when the cold weather and back-to- school children are expecting further increase.

Key questions: How can we make this change without losing a strong defense against the worst consequences of COVID-19? And what is the right choice to aim for? After the huge growth of ohmmicrons in the winter, this genetically distinct mutant sibling is now a major threat, including one that raises the current wave of infections in the United States.

The Food and Drug Administration held a meeting in late June for its scientific advisors to discuss these questions and review data on potential new formulations from vaccine development trials. Pfizer is also studying a combination vaccine, which scientists call the bivalent vaccine.

Moderna said her new study showed that one month after the combined injection, recipients had higher levels of anti-omecro antibodies-and cross-protection from other earlier variants-than the original. and vaccines. However, antibodies naturally decrease, so it is not known how long the protection against infection will last.

The study was conducted on 437 people and safety is similar to today’s amplifiers, Moderna said. The findings were announced in a press release and have not been the subject of a scientific review.

Source: Huffpost

- A word from our sponsors -

Most Popular

LEAVE A REPLY

Please enter your comment!
Please enter your name here

More from Author

- A word from our sponsors -

Read Now

James Gunn confirms post-credit scene in ‘Superman’

With the next launch, the new creative director of the DC universe, James Gunn, confirms that 'Superman' will have scenes you creditsThe premiere of the new Steel Man movie is getting closer and closer and with it news is being released by the producers. 'Superman' will be...

Blackpink’s Jennie joins the list of ‘best albums of 2025, so far’

Blackpink member Jennie enters the list of 'best albums of 2025, so far' pleasing criticism; look!DIVA! With great influence on the music industry, Rolling Stone magazine shares annually in early June the 66 albums considered by its critics the best of the year so far. Including all...

5 Pixar movies that everyone needs to watch

In addition to Toy Story, who was the studio's first long -term movie; Check out 5 more Pixar animations that everyone needs to watch!How many Pixar movies have you watched? The studio, which emerged independently on February 3, 1986 launching only short films, took an important step...

What films make up the age of Disney’s Renaissance?

Find out what are the films responsible for composing one of the most loved eras by fans of Disney productions: the RenaissanceWith over 100 years of history, Disney is one of the main companies of world entertainment. Over the course of a century, the studio was responsible...